Latest Pharmaceutical industry in the People's Republic of China Stories
NASDAQ: CRME TSX: COM VANCOUVER, March 26, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME) (TSX:COM) today announces changes to the company's senior management team. William Hunter, M.D., previously interim Chief Executive Officer and Director, has been appointed full time President and Chief Executive Officer; Karim Lalji has been promoted from Senior Vice President of Commercial Affairs to Chief Commercial Officer; and Sheila Grant has been hired as Chief Operating...
TORONTO, March 26, 2013 /PRNewswire/ - Bontan Corporation Inc. ('the Company") (OTCBB: BNTNF) ("Bontan") is pleased to announce that it has signed a letter of intent with Portage Pharma Ltd., a private limited company formed under the laws of The British Virgin Islands ("Portage") to acquire all the issued and outstanding shares of Portage in exchange for approximately 81.7 million shares of Bontan. Approximately 71.4 million shares of Bontan, equal to the total number of warrants...
New White Paper from Paul Bender questions parallel legislative efforts in the Senate WASHINGTON, March 25, 2013 /PRNewswire-USNewswire/ -- On the day the U.S. Supreme Court hears oral arguments in FTC v. Actavis, a case that challenges the rights of brand-name and generic drug manufacturers to settle patent litigation out of court, Paul Bender, who served as Principal Deputy Solicitor General under President Bill Clinton, has released a new white paper on the topic. Bender,...
- Revenue and Net Profit Surged 35.7% and 9.8%, Respectively - HONG KONG, March 25, 2013 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription drug market, today announced its annual results for the year ended 31 December 2012. Financial Highlights...
NANJING, China, March 22, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Chinese SFDA has issued its approval for GMP certification of the influenza vaccine production facility at Jiangsu Simcere Vaxtec Bio-Pharmaceutical Co., Ltd ("Simcere Vaxtec"), a subsidiary in...
CEDAR RAPIDS, Iowa, March 20, 2013 /PRNewswire/ -- Bill Stamats, Vice President of Business Development for Stamats Healthcare Marketing, announced significant team additions this week. Two client development representatives have been hired to support Stamats' strong business growth. (Logo: http://photos.prnewswire.com/prnh/20130320/CG80061LOGO) New hire, Theresa Lemek, has been involved with new business development and consulting in the healthcare industry for over 10 years. Prior...
NEW YORK, March 20, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the pharmacy automation systems market was valued at USD 4.7 billion in 2011 globally and is expected to grow to USD 7.8 billion by 2018, at a CAGR of 7.3% from 2012 to 2018. Automated technologies in...
GLEN ALLEN, Va., March 18, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: STSI) today filed its annual financial report on Form 10-K with the Securities & Exchange Commission (SEC). The Company reported net sales for the year ended December 31, 2012 of $6.2 million, a five-fold increase over 2011 net sales of $1.2 million. Fourth-quarter 2012 net sales totaled $2.0 million, compared with $0.8 million in fourth-quarter 2011. Net sales of the Company's Anatabloc® dietary...
NEW YORK, March 18, 2013 /PRNewswire/ -- Today, Wall Street Source announced new research reports highlighting Gilead Sciences, Inc. (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Sinovac Biotech Ltd. (NASDAQ: SVA), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Gilead Sciences,...
DUBLIN, March 15, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Biosimilars Market - Products, Applications and Regulations [http://www.researchandmarkets.com/research/xn2btj/global ]" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19.4bn by 2018 Several of the leading 25 manufacturers of...
